Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system

Projektinformationen

Toopi-Regen

ID Finanzhilfevereinbarung: 101144691

DOI

10.3030/101144691

Projekt abgeschlossen

EK-Unterschriftsdatum 5 März 2024

Startdatum 1 Januar 2024

Enddatum 31 Dezember 2025

Finanziert unter

• The European Innovation Council (EIC)

Gesamtkosten

€ 3 423 510,00

EU-Beitrag

€ 2 396 457,00

Koordiniert durch

TOOPI ORGANICS
France

Periodic Reporting for period 1 - Toopi-Regen (Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system)

Berichtszeitraum: 2024-01-01 bis 2024-12-31

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

The global food system faces a dual challenge: ensuring food security while preserving natural resources. Every year in the EU, 18 million tons of mineral fertilizers are used to sustain agricultural yields. However, this practice threatens ecosystems, contributes to climate change, and endangers human health. Meanwhile, a valuable resource, human urine, rich in essential nutrients (N, P, K), is wasted, flushed with drinking water, and polluting aquatic ecosystems.

Toopi Organics addresses these pressing issues through an innovative solution: upcycling human urine into microbial biostimulants using a patented fermentation process. This approach offers farmers an effective, safe, and sustainable alternative to traditional fertilizers. Our biostimulants enhance nutrient use efficiency, increase soil biodiversity, and significantly reduce greenhouse gas emissions from fertilizers.

Supported by the EIC Accelerator, our project aims to scale this closed-loop regenerative agricultural model across Europe. By 2027, we plan to deploy our system in key agricultural countries like Germany, Belgium, the Netherlands, Spain, Portugal, and Italy. The ultimate objective is to substitute a significant share of mineral fertilizers, contributing to the €230B global fertilizer market while promoting sustainable farming practices and improving farmers’ profitability.

This project aligns with EU priorities on circular economy, climate action, and sustainable agriculture, offering a scalable and replicable solution to global environmental challenges.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

In 2024, the project achieved significant milestones in key technical and scientific areas:

Urine Collection Optimization (WP1):
We developed solutions to ensure a consistent quality of urine collection in buildings, achieving a high compliance at rest areas.

Field Trials (WP2):
Several field trials were conducted in Europe during the 2024 spring and autumn seasons. These trials provided valuable preliminary insights into the efficacy of our biostimulants under diverse soil and climatic conditions. Further trials are planned for 2025 to strengthen these findings.

Market Studies (WP3):
Initial market analyses confirmed strong potential in several countries, supported by growing interest in circular economy practices. However, key analyses, such as SWOT assessments and segmentation, will be completed in 2025 to refine our market entry strategy.

These achievements form a strong foundation for scaling our solution and advancing sustainable agriculture in Europe.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

Toopi Organics is redefining fertilizer innovation with a groundbreaking approach that integrates waste valorization and regenerative agriculture. Our patented fermentation process transforms urine into high-value biostimulants, offering a dual benefit of waste reduction and sustainable farming solutions.

Key results achieved so far include:

Technological Innovation: Effective stabilization of urine quality ensures scalability and compliance.
Preliminary Field Trial Success: Trials demonstrate promising performance across diverse conditions, highlighting the adaptability of our biostimulants.
Market Potential: Positive reception in target countries underscores a growing demand for sustainable solutions.
Future steps include improving technical processes, completing market studies, and addressing regulatory challenges. Building strategic partnerships and enhancing awareness among stakeholders are critical to unlocking the full potential of this innovation.

toopi-logo-baseline-principal.png